Sign in
4

Changes in Ownership

Avalo Therapeutics, Inc. Filed Acc 0001567619-21-014631

Director bought 150,000 shares at an average $2.72 ($408,515)

From the SEC's structured data for this filing

Trades in this filing

ARMISTICE CAPITAL, LLC · Director

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2021-08-04 Purchase : show line 1 in the form +100,000 $2.69 $268,590 39,200,000 I
2021-08-05 Purchase : show line 2 in the form +25,000 $2.77 $69,295 39,225,000 I
2021-08-06 Purchase : show line 3 in the form +25,000 $2.83 $70,630 39,250,000 I
Open-market purchases · 150,000 sh · avg $2.72 · $408,515
Loading xslF345X03/doc1.xml…